封面
市场调查报告书
商品编码
1944477

全球酵素免疫分析法市场:依产品类型、检体、应用、最终用户、国家及地区划分-产业分析、市场规模、份额及2025年至2032年未来预测

Enzyme Immunoassay Market, By Product Type, By Specimen, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日期: | 出版商: AnalystView Market Insights | 英文 321 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2024 年,酵素免疫分析法市场规模将达到 178.5009 亿美元,并预计从 2025 年到 2032 年将以 3.87% 的复合年增长率成长。

酵素免疫分析法(EIA) 是一种生化分析技术,它利用抗原-抗体反应的高特异性来检测和定量特定物质,例如抗原、抗体、荷尔蒙、蛋白质和药物。在该方法中,酵素与抗体或抗原化学连接,并作为讯号产生器。当目标分子与相应的抗体结合时,连接的酵素会催化与添加的基材反应,产生可测量的讯号(通常是颜色变化、萤光或发光)。

酵素免疫分析法市场动态

慢性病和感染疾病的增加,以及诊断基础设施的不断完善,预计将推动市场需求。

爱滋病、肝炎、结核病和新发病毒感染疾病等感染疾病的日益流行是推动酵素免疫分析法市场成长的主要因素。酵素免疫分析法因其高准确度、高特异性和成本效益,被广泛应用于早期诊断、大规模筛检和确诊检测。同时,心血管疾病、癌症、自体免疫疾病和糖尿病等慢性疾病的日益普遍,进一步推动了可靠且高效诊断解决方案的需求。酵素免疫分析法对于识别疾病特异性生物标记、荷尔蒙和抗体至关重要,从而能够实现及时诊断和疾病进展的持续监测。随着全球医疗保健系统越来越重视预防保健、早期检测和改善患者预后,基于酵素免疫分析的诊断检测在全球各地的医院、临床检查室和诊断中心的应用正在稳步扩展。

酵素免疫分析法平台技术的持续进步,包括改进的ELISA试剂盒、先进的自动化技术、多重检测能力以及更高效的酵素和基材的开发,正显着推动市场扩张。自动化和半自动化的EIA系统尤其受到现代临床检查室的青睐,因为它们能够提高检测效率、最大限度地减少人为误差并实现高通量分析。此外,在政府扶持政策和私部门投资不断增长的推动下,新兴经济体医疗保健和诊断基础设施的快速发展,也扩大了先进诊断解决方案的普及范围。酵素免疫分析法在药物研发、疫苗开发和临床试验的应用日益广泛,也推动了市场需求。技术创新与基础设施建设的结合,正在加速酵素免疫分析法在全球的应用,无论其应用领域是临床、研究或工业。

酵素免疫分析法市场:細項分析

全球酵素免疫分析法市场按产品类型、检体、应用、最终用户和地区进行细分。

根据检体,检测可分为五大类:血液、尿液、唾液和其他。血液样本因其诊断可靠性高、临床应用广泛,在检体类别中占据主导地位。血液检体中含有高浓度的生物标记物,例如抗原、抗体、荷尔蒙和蛋白质,这使得酵素免疫分析法)能够展现出极佳的灵敏度和特异性。血液检测在医院、诊断检查室和研究实验室的广泛应用,进一步提升了该类别的收入份额。

根据应用领域,市场可分为六大类:感染疾病、心臟病、肿瘤、自体免疫疾病、治疗药物监测及其他。受全球感染疾病感染疾病将占据最大的市场份额。爱滋病、B肝、C肝、结核病、流感以及其他病毒和细菌性行为感染等疾病仍然是重大的公共卫生挑战,尤其是在人口稠密和发展中地区。这种持续的疾病负担催生了对准确、快速且经济高效的诊断方法的强烈需求。

酵素免疫分析法市场—区域分析

全球酵素免疫分析法市场按地区划分为北美、拉丁美洲、欧洲、亚太以及中东和非洲。北美占据酵素免疫分析法市场的大部分份额,这主要得益于其先进的检查室基础设施、高额的医疗保健支出、自动化免疫检测技术的早期应用以及大型诊断公司的强大影响力。欧洲紧随其后,这主要得益于其健全的公共医疗保健体系、广泛的常规筛检计画以及对感染疾病和慢性病早期检测的日益重视。亚太地区是成长最快的市场,这主要得益于医疗保健服务覆盖范围的扩大、疾病负担的加重、人们对早期诊断检测意识提升以及政府和私营企业(尤其是在中国和印度等国家)对检查室基础设施的大量投资。拉丁美洲市场也呈现稳定成长态势,这主要归功于医疗保健基础设施的持续改善和诊断检测量的不断增加。

目录

第一章酵素免疫分析法市场概述

  • 分析范围
  • 市场估算期

第二章执行摘要

  • 市场区隔
  • 竞争考察

第三章酵素免疫分析法的关键市场趋势

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 未来市场趋势

第四章酵素免疫分析法市场:产业分析

  • PEST分析
  • 波特五力分析
  • 市场成长展望:概览
  • 管理体制分析

第五章酵素免疫分析法市场:地缘政治紧张局势加剧的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章酵素免疫分析法市场概况

  • 酵素免疫分析法市场占有率分析(2024 年)
  • 主要製造商的细分数据
    • 对现有公司的分析
    • 新兴企业分析

第七章酵素免疫分析法市场:依产品类型划分

  • 概述
    • 细分市场占有率分析:依产品类型
    • 试剂和试剂盒
    • 装置
    • 软体和服务

第八章 依检体的酵素免疫分析法市场

  • 概述
    • 细分市场占有率分析:按检体
    • 尿
    • 唾液
    • 其他的

第九章酵素免疫分析法市场:依应用划分

  • 概述
    • 细分市场占有率分析:按应用
    • 感染疾病
    • 心臟病学
    • 肿瘤学
    • 自体免疫疾病
    • 治疗药物监测
    • 其他的

第十章 依最终用户分類的酵素免疫分析法市场

  • 概述
    • 细分市场占有率分析:依最终用户划分
    • 医院
    • 诊断检查室
    • 製药和生物技术公司
    • 学术研究
    • 其他的

第十一章酵素免疫分析法市场(按地区划分)

  • 介绍
  • 北美洲
    • 概述
    • 北美主要製造商
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲主要製造商
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 其他的
  • 亚太地区
    • 概述
    • 亚太地区主要製造商
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 其他的
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他的
  • 中东和非洲(MEA)
    • 概述
    • 中东和非洲的主要製造商
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他的

第十二章 主要供应商分析—酵素免疫分析法产业

  • 竞争对手仪錶板
    • 竞争基准
    • 竞争定位
  • 公司简介
    • Siemens Healthineers
    • Danaher Corporation
    • Thermo Fisher Scientific
    • F. Hoffmann-La Roche AG
    • Abbott Laboratories
    • Bio-Rad Laboratories
    • bioMerieux SA
    • QuidelOrtho Corporation
    • Becton, Dickinson and Company
    • Sysmex Corporation
    • PerkinElmer(Revvity)
    • Agilent Technologies
    • Merck KGaA
    • DiaSorin SpA
    • Randox Laboratories
    • VION Biosciences
    • Others

第十三章:分析师视角360度分析

简介目录
Product Code: ANV6012

Enzyme Immunoassay Market size was valued at USD 17,850.09 Million in 2024, expanding to a CAGR of 3.87% from 2025 to 2032.

Enzyme Immunoassay (EIA) is a biochemical analytical technique used to detect and quantify specific substances such as antigens, antibodies, hormones, proteins, or drugs by exploiting the high specificity of antigen antibody interactions. In this method, an enzyme is chemically linked to an antibody or antigen and acts as a signal generator. When the target molecule binds to its corresponding antibody, the attached enzyme catalyzes a reaction with an added substrate, producing a measurable signal, usually a color change, fluorescence, or luminescence.

Enzyme Immunoassay Market- Market Dynamics

Increasing prevalence of chronic, infectious diseases and expansion of diagnostic infrastructure are expected to propel market demand

The rising incidence of infectious diseases such as HIV, hepatitis, tuberculosis, and newly emerging viral infections is a key factor driving growth in the enzyme immunoassay market. Enzyme immunoassays are extensively used for early diagnosis, large-scale screening, and confirmatory testing because they offer high accuracy, strong specificity, and cost-effective performance. At the same time, the increasing prevalence of chronic diseases including cardiovascular diseases, cancer, autoimmune conditions, and diabetes has intensified the need for dependable and efficient diagnostic solutions. Enzyme immunoassays are essential for identifying disease-specific biomarkers, hormones, and antibodies, enabling timely diagnosis and continuous monitoring of disease progression. With healthcare systems worldwide placing greater emphasis on preventive care, early detection, and improved patient outcomes, the use of EIA-based diagnostic tests is steadily expanding across hospitals, clinical laboratories, and diagnostic centers across the globe.

Ongoing technological advancements in enzyme immunoassay platforms such as improved ELISA kits, greater automation, multiplex testing capabilities, and the development of more efficient enzymes and substrates, are significantly contributing to market expansion. Automated and semi-automated EIA systems enhance testing efficiency, minimize manual errors, and enable high-throughput analysis, making them especially appealing to modern clinical laboratories. In addition, the rapid development of healthcare and diagnostic infrastructure in emerging economies, driven by supportive government policies and increased private-sector investment, has broadened access to advanced diagnostic solutions. The expanding application of enzyme immunoassays in pharmaceutical research, vaccine development, and clinical trial activities is also boosting market demand. Collectively, technological innovation and infrastructure growth are accelerating the widespread adoption of enzyme immunoassays across clinical, research, and industrial settings worldwide.

Enzyme Immunoassay Market- Segmentation Analysis:

The Global Enzyme Immunoassay Market is segmented on the basis of Product Type, Specimen, Application, End User, and Region.

The market is divided into five categories based on Specimen: blood, urine, saliva, and others. Blood segment in the specimen is primarily held major share because of its high diagnostic reliability and broad clinical applicability. Blood-based samples provide higher concentrations of biomarkers such as antigens, antibodies, hormones, and proteins, enabling enzyme immunoassays to deliver superior sensitivity and specificity. The widespread use of blood tests in hospitals, diagnostic laboratories, and research settings further boosts this segment's revenue share.

The market is divided into six categories based on Application: infectious diseases, cardiology, oncology, autoimmune disorders, therapeutic drug monitoring, and others. The infectious diseases segment held the majority market share in 2024, driven by the consistently high prevalence and incidence of infectious diseases across the globe. Conditions such as HIV/AIDS, hepatitis B and C, tuberculosis, influenza, and other viral and bacterial infections continue to pose significant public health challenges, particularly in densely populated and developing regions. This sustained disease burden has created strong demand for accurate, rapid, and cost-effective diagnostic methods.

Enzyme Immunoassay Market- Geographical Insights

Across the globe, the Enzyme Immunoassay market is split in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America accounts for the substantial share of the enzyme immunoassay market, driven by its advanced laboratory infrastructure, substantial healthcare expenditure, early adoption of automated immunoassay technologies, and the strong presence of major diagnostic companies. Followed by Europe which is supported by robust public healthcare systems, widespread routine screening programs, and increasing emphasis on early detection of infectious and chronic diseases. The Asia Pacific region represents the fastest-growing market, propelled by expanding access to healthcare services, a rising burden of diseases, greater awareness of early diagnostic testing, and significant investments in laboratory infrastructure by both governments and private players, particularly in countries such as China and India. Latin America is experiencing steady growth due to ongoing improvements in healthcare infrastructure and increasing volumes of diagnostic testing.

Italy Enzyme Immunoassay Market- Key Insights

China stands out as a major country in the Asia Pacific region and rapidly expanding country-level market within the enzyme immunoassay (EIA) sector. Growth is largely fueled by its vast population, the rising incidence of infectious and chronic diseases, and a growing need for timely and accurate diagnostic solutions. Government-led efforts to enhance public healthcare systems, broaden disease screening initiatives, and upgrade laboratory infrastructure have significantly accelerated the uptake of enzyme immunoassays in hospitals and diagnostic centers. Additionally, the strong expansion of China's biotechnology and pharmaceutical industries has increased the use of EIAs in areas such as drug discovery, vaccine development, and clinical research. Greater awareness of preventive healthcare, along with increasing adoption of automated and high-throughput immunoassay technologies, continues to drive steady and long-term growth of the EIA market in China.

Enzyme Immunoassay Market- Competitive Landscape:

The enzyme immunoassay (EIA) market is characterized by intense competition, with a mix of global healthcare conglomerates and specialized diagnostic companies competing to strengthen their market positions. Leading players such as Siemens Healthineers, Danaher Corporation, Bio-Rad Laboratories, bioMerieux SA, and QuidelOrtho maintain strong competitiveness through extensive product portfolios, advanced immunoassay platforms, and well-established global distribution networks. These companies focus heavily on continuous innovation, offering automated and high-throughput enzyme immunoassay systems that improve laboratory efficiency, accuracy, and turnaround times. Significant investments in research and development enable them to regularly introduce new and improved assay kits targeting infectious diseases, chronic conditions, and specialized diagnostic applications.

Recent Developments:

In 2025, Revvity Inc. introduced the IDS i20, a fully automated chemiluminescence immunoassay solution, empowering multi-specialty testing on a single system which enhance workflow efficiency for clinical labs.

In February 2025, VION Biosciences completed the acquisition of BioAssay Systems, a company known for its expertise in high-throughput enzyme immunoassay technologies. This strategic move enhanced VION's footprint in the diagnostics and life sciences tools.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ENZYME IMMUNOASSAY MARKET KEY PLAYERS

  • Siemens Healthineers
  • Danaher Corporation
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Bio-Rad Laboratories
  • bioMerieux SA
  • QuidelOrtho Corporation
  • Becton, Dickinson and Company
  • Sysmex Corporation
  • PerkinElmer (Revvity)
  • Agilent Technologies
  • Merck KGaA
  • DiaSorin S.p.A.
  • Randox Laboratories
  • VION Biosciences
  • Others

GLOBAL ENZYME IMMUNOASSAY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032

  • Reagents & Kits
  • Instruments
  • Software & Services

GLOBAL ENZYME IMMUNOASSAY MARKET, BY SPECIMEN- MARKET ANALYSIS, 2019-2032

  • Blood
  • Urine
  • Saliva
  • Others

GLOBAL ENZYME IMMUNOASSAY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Infectious diseases
  • Cardiology
  • Oncology
  • Autoimmune disorders
  • Therapeutic drug monitoring
  • Others

GLOBAL ENZYME IMMUNOASSAY MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospitals
  • Diagnostic Laboratories
  • Pharmaceutical & Biotech Companies
  • Academic Research
  • Others

GLOBAL ENZYME IMMUNOASSAY MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Enzyme Immunoassay Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Enzyme Immunoassay Market Snippet by Product Type
    • 2.1.2. Enzyme Immunoassay Market Snippet by Specimen
    • 2.1.3. Enzyme Immunoassay Market Snippet by Application
    • 2.1.4. Enzyme Immunoassay Market Snippet by End User
    • 2.1.5. Enzyme Immunoassay Market Snippet by Country
    • 2.1.6. Enzyme Immunoassay Market Snippet by Region
  • 2.2. Competitive Insights

3. Enzyme Immunoassay Key Market Trends

  • 3.1. Enzyme Immunoassay Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Enzyme Immunoassay Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Enzyme Immunoassay Market Opportunities
  • 3.4. Enzyme Immunoassay Market Future Trends

4. Enzyme Immunoassay Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Enzyme Immunoassay Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Enzyme Immunoassay Market Landscape

  • 6.1. Enzyme Immunoassay Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Enzyme Immunoassay Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Reagents & Kits
    • 7.1.3. Instruments
    • 7.1.4. Software & Services

8. Enzyme Immunoassay Market - By Specimen

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Specimen, 2024 & 2032 (%)
    • 8.1.2. Blood
    • 8.1.3. Urine
    • 8.1.4. Saliva
    • 8.1.5. Others

9. Enzyme Immunoassay Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Infectious diseases
    • 9.1.3. Cardiology
    • 9.1.4. Oncology
    • 9.1.5. Autoimmune disorders
    • 9.1.6. Therapeutic drug monitoring
    • 9.1.7. Others

10. Enzyme Immunoassay Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Specimen, 2024 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Diagnostic Laboratories
    • 10.1.4. Pharmaceutical & Biotech Companies
    • 10.1.5. Academic Research
    • 10.1.6. Others

11. Enzyme Immunoassay Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Enzyme Immunoassay Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Enzyme Immunoassay Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Enzyme Immunoassay Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Enzyme Immunoassay Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Enzyme Immunoassay Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Specimen, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Enzyme Immunoassay Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Siemens Healthineers
    • 12.2.2. Danaher Corporation
    • 12.2.3. Thermo Fisher Scientific
    • 12.2.4. F. Hoffmann-La Roche AG
    • 12.2.5. Abbott Laboratories
    • 12.2.6. Bio-Rad Laboratories
    • 12.2.7. bioMerieux SA
    • 12.2.8. QuidelOrtho Corporation
    • 12.2.9. Becton, Dickinson and Company
    • 12.2.10. Sysmex Corporation
    • 12.2.11. PerkinElmer (Revvity)
    • 12.2.12. Agilent Technologies
    • 12.2.13. Merck KGaA
    • 12.2.14. DiaSorin S.p.A.
    • 12.2.15. Randox Laboratories
    • 12.2.16. VION Biosciences
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us